138 related articles for article (PubMed ID: 27206918)
1. Optimization of Folate-Targeted Immunotherapy for the Treatment of Experimental Arthritis.
Varghese B; Paulos C; Low PS
Inflammation; 2016 Aug; 39(4):1345-53. PubMed ID: 27206918
[TBL] [Abstract][Full Text] [Related]
2. Folate-targeted hapten immunotherapy of adjuvant-induced arthritis: comparison of hapten potencies.
Yi YS; Ayala-López W; Kularatne SA; Low PS
Mol Pharm; 2009; 6(4):1228-36. PubMed ID: 19374407
[TBL] [Abstract][Full Text] [Related]
3. Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis.
Paulos CM; Varghese B; Widmer WR; Breur GJ; Vlashi E; Low PS
Arthritis Res Ther; 2006; 8(3):R77. PubMed ID: 16646988
[TBL] [Abstract][Full Text] [Related]
4. Folate receptor-targeted immunotherapy: induction of humoral and cellular immunity against hapten-decorated cancer cells.
Lu Y; Sega E; Low PS
Int J Cancer; 2005 Sep; 116(5):710-9. PubMed ID: 15828051
[TBL] [Abstract][Full Text] [Related]
5. Low-dose radiation potentiates the therapeutic efficacy of folate receptor-targeted hapten therapy.
Sega EI; Lu Y; Ringor M; Leamon CP; Low PS
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):559-66. PubMed ID: 18411004
[TBL] [Abstract][Full Text] [Related]
6. Preclinical pharmacokinetics, tissue distribution, and antitumor activity of a folate-hapten conjugate-targeted immunotherapy in hapten-immunized mice.
Lu Y; Xu LC; Parker N; Westrick E; Reddy JA; Vetzel M; Low PS; Leamon CP
Mol Cancer Ther; 2006 Dec; 5(12):3258-67. PubMed ID: 17172429
[TBL] [Abstract][Full Text] [Related]
7. Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis.
Paulos CM; Turk MJ; Breur GJ; Low PS
Adv Drug Deliv Rev; 2004 Apr; 56(8):1205-17. PubMed ID: 15094216
[TBL] [Abstract][Full Text] [Related]
8. Depletion of folate-receptor-positive macrophages leads to alleviation of symptoms and prolonged survival in two murine models of systemic lupus erythematosus.
Varghese B; Haase N; Low PS
Mol Pharm; 2007; 4(5):679-85. PubMed ID: 17848087
[TBL] [Abstract][Full Text] [Related]
9. Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.
Lu Y; Sega E; Leamon CP; Low PS
Adv Drug Deliv Rev; 2004 Apr; 56(8):1161-76. PubMed ID: 15094213
[TBL] [Abstract][Full Text] [Related]
10. Folate-conjugated liposomes target and deliver therapeutics to immune cells in a rat model of rheumatoid arthritis.
Poh S; Chelvam V; Kelderhouse LE; Ayala-López W; Vaitilingam B; Putt KS; Low PS
Nanomedicine (Lond); 2017 Oct; 12(20):2441-2451. PubMed ID: 28972462
[TBL] [Abstract][Full Text] [Related]
11. Folate-targeted dinitrophenyl hapten immunotherapy: effect of linker chemistry on antitumor activity and allergic potential.
Lu Y; You F; Vlahov I; Westrick E; Fan M; Low PS; Leamon CP
Mol Pharm; 2007; 4(5):695-706. PubMed ID: 17784727
[TBL] [Abstract][Full Text] [Related]
12. Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors.
Lu Y; Low PS
Cancer Immunol Immunother; 2002 May; 51(3):153-62. PubMed ID: 11941454
[TBL] [Abstract][Full Text] [Related]
13. Depletion of activated macrophages with a folate receptor-beta-specific antibody improves symptoms in mouse models of rheumatoid arthritis.
Hu Y; Wang B; Shen J; Low SA; Putt KS; Niessen HWM; Matteson EL; Murphy L; Ruppert C; Jansen G; Oliver SJ; Feng Y; Dimitrov DS; Nickerson-Nutter C; Low PS
Arthritis Res Ther; 2019 Jun; 21(1):143. PubMed ID: 31174578
[TBL] [Abstract][Full Text] [Related]
14. Folate-Hapten-Mediated Immunotherapy Synergizes with Vascular Endothelial Growth Factor Receptor Inhibitors in Treating Murine Models of Cancer.
Bandara NA; Bates CD; Lu Y; Hoylman EK; Low PS
Mol Cancer Ther; 2017 Mar; 16(3):461-468. PubMed ID: 27980109
[TBL] [Abstract][Full Text] [Related]
15. Folate-targeted nanoparticles for rheumatoid arthritis therapy.
Nogueira E; Gomes AC; Preto A; Cavaco-Paulo A
Nanomedicine; 2016 May; 12(4):1113-1126. PubMed ID: 26733257
[TBL] [Abstract][Full Text] [Related]
16. Arthritis imaging using a near-infrared fluorescence folate-targeted probe.
Chen WT; Mahmood U; Weissleder R; Tung CH
Arthritis Res Ther; 2005; 7(2):R310-7. PubMed ID: 15743478
[TBL] [Abstract][Full Text] [Related]
17. Targeted therapy of rheumatoid arthritis via macrophage repolarization.
Zhou X; Huang D; Wang R; Wu M; Zhu L; Peng W; Tu H; Deng X; Zhu H; Zhang Z; Wang X; Cao X
Drug Deliv; 2021 Dec; 28(1):2447-2459. PubMed ID: 34766540
[TBL] [Abstract][Full Text] [Related]
18. Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate.
Lu Y; Stinnette TW; Westrick E; Klein PJ; Gehrke MA; Cross VA; Vlahov IR; Low PS; Leamon CP
Arthritis Res Ther; 2011 Apr; 13(2):R56. PubMed ID: 21463515
[TBL] [Abstract][Full Text] [Related]
19. Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis.
Turk MJ; Breur GJ; Widmer WR; Paulos CM; Xu LC; Grote LA; Low PS
Arthritis Rheum; 2002 Jul; 46(7):1947-55. PubMed ID: 12124880
[TBL] [Abstract][Full Text] [Related]
20. Strategy to prevent drug-related hypersensitivity in folate-targeted hapten immunotherapy of cancer.
Lu Y; Klein PJ; Westrick E; Xu LC; Santhapuram HK; Bloomfield A; Howard SJ; Vlahov IR; Ellis PR; Low PS; Leamon CP
AAPS J; 2009 Sep; 11(3):628-38. PubMed ID: 19728104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
